SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, TOB, sox040713, Astavakra, TheHound
Search This Board:
Last Post: 12/11/2016 2:44:14 AM - Followers: 699 - Board type: Free - Posts Today: 2

Cellceutix Corporation (CTIX)
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
About Cellceutix: 

Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Cellceutix is now preparing its FDA application for a Phase 2 ovarian cancer study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. Brilacidin-OM, a defensin mimetic compound, has shown in an animal model to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol completed a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (Superbugs). Brilacidin is also being evaluated in a Phase 2 Proof-of-Concept trial as a novel treatment for Ulcerative Proctitis. Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site at www.cellceutix.com. 

Management:  http://cellceutix.com/team/

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

 

Upcoming Milestones:
 


Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings (CIK:0001355250):  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:

EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275

 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CTIX News: Current Report Filing (8-k) 11/15/2016 06:25:29 AM
CTIX News: Quarterly Report (10-q) 11/09/2016 06:06:41 AM
CTIX News: Amended Annual Report (10-k/a) 10/28/2016 05:02:25 PM
CTIX News: Current Report Filing (8-k) 09/15/2016 08:01:38 AM
CTIX News: Current Report Filing (8-k) 09/13/2016 08:01:27 AM
PostSubject
#165552  Sticky Note B-UP Due Diligence sox040713 12/09/16 12:17:52 PM
#165491  Sticky Note New Oral Psoriasis Drug Tops Cellceutix Catalysts $CTIX http://www.seekingalpha. Matagordaville 12/08/16 04:55:12 PM
#165310  Sticky Note News: Cellceutix Phase 2 Trial Dose Escalates in BooDog 12/07/16 07:40:13 AM
#163870  Sticky Note Cellceutix Q1 Fiscal 2017 Conference Call BooDog 11/15/16 10:13:00 AM
#162983  Sticky Note CTIX Upcoming and Past Milestones, Clinical Trials, Recent Interviews sox040713 11/01/16 12:36:11 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#165661   FDA Get out of the way! george h 12/11/16 02:44:14 AM
#165660   His allegiance is with patients with OM. Jhawker 12/11/16 12:54:13 AM
#165659   Detonate they have to get a partner or JTORENCE 12/10/16 09:32:00 PM
#165658   I disagree with you luxe. "but the SP says thefamilyman 12/10/16 08:53:19 PM
#165657   Hound-this guy is on CTIX scientific medical board JTORENCE 12/10/16 08:32:43 PM
#165656   SGX942 study is IV 2x week after radiation morecoffee 12/10/16 08:21:20 PM
#165655   Wouldn't a guy with these credentials, and a stevo99 12/10/16 08:07:09 PM
#165654   Just trying to set you men straight! runninggirl2016 12/10/16 07:54:48 PM
#165653   I love it when you are on your EasyRider 12/10/16 07:53:30 PM
#165651   SGX942 is NOT a prevention as B-OM is intended. runninggirl2016 12/10/16 07:14:57 PM
#165650   it's Sonis not Sonix. perhaps because he's our TheHound 12/10/16 06:44:07 PM
#165649   Hound thanks for posting that info. I was Jhawker 12/10/16 06:35:37 PM
#165648   did u see where SGX-942 is an IV TheHound 12/10/16 06:23:43 PM
#165647   I agree with your agree! Jhawker 12/10/16 04:34:02 PM
#165646   Agree. CTIX has great potential for a Detonate 12/10/16 03:47:37 PM
#165645   If this should happen I shall raise a Detonate 12/10/16 03:36:21 PM
#165644   Anyone care to do a little DD on JTORENCE 12/10/16 03:31:35 PM
#165643   Prurisol Oral psoriasis drug candidate in a Phase BooDog 12/10/16 03:28:52 PM
#165642   It's just the cash position. And maybe DaubersUP 12/10/16 03:25:49 PM
#165641   stevo99 why would Dr.Sonix help us get a grant? JTORENCE 12/10/16 03:11:13 PM
#165640   buy dips noretreat 12/10/16 02:11:12 PM
#165639   DaubersUP $BILLIONS not $millions. georgejjl 12/10/16 02:03:15 PM
#165637   no post about Prurisol and how it works To infinity and beyond! 12/10/16 12:53:21 PM
#165636   You're right. Stay the course BioHedge 12/10/16 12:53:04 PM
#165635   A BIG deal for Prurisol will do that:) runninggirl2016 12/10/16 12:40:28 PM
#165634   I wish I will wake up one day(soon) vip1999 12/10/16 12:24:07 PM
#165633   There is a lot on Cellceutix's plate moving BooDog 12/10/16 11:43:56 AM
#165632   nerby Did a little DD on this company. JTORENCE 12/10/16 11:40:50 AM
#165631   I'd also like to see the B-OM trial nerby 12/10/16 11:24:21 AM
#165630   I prefer to regard this as my being Detonate 12/10/16 11:14:14 AM
#165629   I sure hope B-OM motors along quickly....looks like stevo99 12/10/16 10:57:20 AM
#165628   but the SP says they have failed we runninggirl2016 12/10/16 10:55:19 AM
#165627   CTIX jumping to 4 times today's price would Detonate 12/10/16 10:53:03 AM
#165626   If there are negotiations it has to be runninggirl2016 12/10/16 09:33:13 AM
#165625   I'd recommend some quality homemade iced-tea. It's scottsmith 12/10/16 08:08:08 AM
#165624   The Balvenies are terrific. The Macallan has a TheDane 12/10/16 07:35:28 AM
#165623   A jump to 4 times the price - Amatuer17 12/10/16 07:13:52 AM
#165621   CTIX return to 4.92 would be worth a BigKahuna 12/10/16 02:35:44 AM
#165620   I'll bet CTIX mgmt is in serious negotiations DaubersUP 12/09/16 11:45:27 PM
#165619   I agree! Jhawker 12/09/16 10:17:59 PM
#165618   Seems like an amateur statement to me. I Darwinian 12/09/16 10:09:00 PM
#165617   Frontal lobotomy, or bottle in front of me. TheDane 12/09/16 10:08:20 PM
#165615   30 days away.....Looking forward to the presentation at Matagordaville 12/09/16 09:36:12 PM
#165614   As an investor I really don't need a septmike09 12/09/16 08:59:25 PM
#165613   George it's either next week or wait til runninggirl2016 12/09/16 08:33:37 PM
#165612   Hopefully Monday because we got that black candlestick septmike09 12/09/16 08:29:39 PM
#165611   Well said... Def agree... Ringrock 12/09/16 08:25:16 PM
#165609   I expect more good news next week from Cellceutix. georgejjl 12/09/16 07:51:10 PM
#165608   Hmmmmmmmmm Have a good weekend everyone. 58nout 12/09/16 07:31:48 PM
#165606   FINRA short sales of CTIX AlanC 12/09/16 07:13:39 PM
PostSubject